{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Unity Biotechnology, Inc."},"Symbol":{"label":"Symbol","value":"UBX"},"Address":{"label":"Address","value":"285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, California, 94080, United States"},"Phone":{"label":"Phone","value":"+1 650 416-1192"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells; and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases."},"CompanyUrl":{"label":"Company Url","value":"https://www.unitybiotechnology.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Anirvan Ghosh","title":"Chief Executive Officer & Director"},{"name":"Przemyslaw Sapieha","title":"Chief Scientist"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}